Singapore markets close in 7 hours 38 minutes
Straits Times Index
3,193.37 +5.71 (+0.18%) Nikkei
37,291.60 -788.10 (-2.07%) Hang Seng
16,385.87 0.00 (0.00%) FTSE 100
7,877.05 +29.06 (+0.37%) Bitcoin USD
62,119.92 +666.77 (+1.09%) CMC Crypto 200
1,295.42 +409.88 (+46.29%)
Adaptimmune Therapeutics plc (ADAP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.9870 |
| Open | 0.9676 |
| Bid | 0.8764 x 1100 |
| Ask | 0.9007 x 100 |
| Day's range | 0.8721 - 0.9893 |
| 52-week range | 0.4200 - 2.0500 |
| Volume | |
| Avg. volume | 1,967,837 |
| Market cap | 229.597M |
| Beta (5Y monthly) | 2.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.
- Simply Wall St.
Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Adaptimmune Therapeutics ( NASDAQ:ADAP ) Full Year 2023 Results Key Financial Results Revenue: US$60.3m (up 122% from...
- GuruFocus.com
Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results
Key Financial Highlights and Business Updates
© 2024 Yahoo. All rights reserved.